#ASCO14 - Poster: Activity of abiraterone acetate in metastatic castration-resistant prostate cancer patients previously treated with ketoconazole: A prospective phase II study from the Prostate Cancer Clinical Trials Consortium

CHICAGO, IL USA (UroToday.com) - Presented by Won Kim, John Wilton, Li Zhang, Amy M. Lin, Lawrence Fong, Andrew Caleb Hsieh, Terence W. Friedlander, Rahul Raj Aggarwal, Vivian K. Weinberg, Allison Morse, Jeffrey Bozeman, Arturo Molina, Gerald J. Fetterly, James Mohler, Russell Zelig Szmulewitz, Eric Jay Small, and Charles J. Ryan at the American Society of Clinical Oncology (ASCO) 50th Annual Meeting - May 30 - June 3, 2014 - Chicago, Illinois USA

asco 2014 kim poster thumb

Click HERE to listen to an exclusive interview with Won Kim, MD, one of the authors of this study

University of California, San Francisco, San Francisco, CA USA; Roswell Park Cancer Institute, Buffalo, NY USA; The University of Chicago Medical Center, Chicago, IL USA; Janssen Research and Development, Menlo Park, CA USA; The University of Chicago, Chicago, IL USA; University of California San Francisco, San Francisco, CA USA

 

 

email news signup